Search

Your search keyword '"Ekenel, Meltem"' showing total 193 results
Start Over Author "Ekenel, Meltem"
193 results on '"Ekenel, Meltem"'

1. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Author

Rischin, Danny, Hughes, Brett GM, Gao, Bo, McGrath, Margaret, Greil, Richard, Thurnher, Dietmar, Fuereder, Thorsten, Burian, Martin, Rottey, Sylvie, Machiels, Jean-Pascal, Clement, Paul M, Henry, Stéphanie, Deheneffe, Stéphanie, Vasconcelos Alves, Gustavo, Lima, Iane Pinto Figueiredo, Mourão Dias, Josiane, De Marchi, Pedro Rafael Martins, Mak, Milena Perez, Pereira de Santana Gomes, Andrea Juliana, Oliveira de Castro Junior, Dalvaro, Motta, Tatiane Cardoso, Agostinho Padoan, Monica Luciana, Victorina, Ana Paula, de Azevedo, Sergio Jobim, Siu, Lillian L, Brule, Stephanie, Hilton, John, Wang, Chang Shu, Bouganim, Nathaniel, Webster, Marc, Walker, John, Chua, Neil, Zambrano, Angela Regina, Quiroga Echeverri, Alicia, Niño Gomez, Oscar Mauricio, Ortiz, Carlos Alberto, Rojas, Luis, Cardona Zorilla, Andrés, Urrego Meléndez, Olga Marcela, Holečková, Petra Beran, Melichar, Bohuslav, Cvek, Jakub, Prausová, Jana, Vošmik, Milan, Delord, Jean-Pierre, Zasadny, Xavier, Geoffrois, Lionnel, Tao, Yungan, Pointreau, Yoann, Fietkau, Rainer, Haderlein, Marlen, Mueller, Andreas H, Schroeder, Ursula, Wollenberg, Barbara, Laban, Simon, Ivanyi, Philipp, Gruenwald, Viktor, Schafhausen, Philippe, Gutfeld, Orit, Gluck, Iris, Popovtzer, Aron, Meirovitz, Amichay, Billan, Salem, Brenner, Baruch, Limon, Dror, Licitra, Lisa, Perri, Francesco, Caponigro, Francesco, Violati, Martina, Ferrari, Daris, Nole, Franco, Bertolini, Federica, Livi, Lorenzo, Ghi, Maria Grazia, Imarisio, Ilaria, Tahara, Makoto, Homma, Akihiro, Ueda, Tsutomu, Asada, Yukinori, Yamazaki, Tomoko, Matsumoto, Koji, Fujii, Takashi, Ikeda, Sadakatsu, Takahashi, Shunji, Kinoshita, Takashi, Sasaki, Keita, Tsuji, Akihito, Ahn, Myung-Ju, Cho, Byoung Chul, Lee, Keun-Wook, Lee, Ki Hyeong, Choi, Moon Ki, Yun, Hwan Jung, Hendriks, Mathijs P, Oosting, Sjoukje F, Buter, Jan, Van Meerten, Esther, Graham, Jonathan, Kawecki, Andrzej, Debicka, Izabella, Maciejczyk, Adam, Pysz, Maciej, Filarska, Dorota, Hetnał, Marcin, Koralewski, Piotr, Wygoda, Andrzej, Składowski, Krzysztof, Talerczyk, Małgorzata, Berrocal Jaime, Alfonso, Pérez Segura, Pedro, Braña García, Irene, Basté Rotllan, Neus, Mesía Nin, Ricard, Taberna Sanz, Miren, Iglesias Docampo, Lara, Soria Rivas, Ainara, Rueda Domínguez, Antonio, Trigo Pérez, José Manuel, Hong, Ruey-Long, Li, Shau-Hsuan, Wang, Hung-Ming, Yen, Chia-Jui, Yang, Muh-Hwa, Chang, Yi-Fang, Liu, Yi-Chun, Lin, Jin-Ching, Ekenel, Meltem, Harputluoğlu, Hakan, Aksoy, Sercan, Özyilkan, Özgür, Bılıcı, Ahmet, Şendur, Mehmet Alı Nahıt, Arslan, Cagatay, Harrington, Kevin, Ramkumar, Shanmugasundaram, Gujral, Dorothy, Stewart, Simon, Powell, Melanie, Sibtain, Amen, Roques, Tom, Yip, Kent, Mirza, Arafat, Sivaramalingam, Muthiah, Belman, Neil D, Agarwala, Sanjiv, Anderson, Ian, Patel, Arpan, Maggiore, Ronald, Baumgart, Megan, Burtness, Barbara, Fidler, Mary Jo, Kaur, Varinder, Gaughan, Elizabeth, Worden, Francis, Rodriguez, Cristina P, Sukari, Ammar, Wong, Deborah, Yom, Sue, Walsh, William V, Fiorillo, Joseph A, Yorio, Jeffrey T, Obara, Grzegorz S, Alves, Gustavo, Hughes, Brett G M, Mesía, Ricard, Taberna, Miren, Waldron, John N, Simon, Christian, Grégoire, Vincent, Harrington, Kevin J, Swaby, Ramona F, Zhang, Yayan, Gumuscu, Burak, and Bidadi, Behzad

Published
2024
Full Text
View/download PDF

2. Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences

Author

Tural, Deniz, Ölmez, Ömer Fatih, Sümbül, Ahmet Taner, Artaç, Mehmet, Özhan, Nail, Akar, Emre, Çakar, Burcu, Köstek, Osman, Ekenel, Meltem, Erman, Mustafa, Coşkun, Hasan Şenol, Selçukbiricik, Fatih, Keskin, Özge, Türköz, Fatma Paksoy, Oruç, Kerem, Bayram, Selami, Yılmaz, Uğur, Bilgetekin, İrem, Yıldız, Birol, Şendur, Mehmet Ali Nahit, Paksoy, Nail, Dirican, Ahmet, Erdem, Dilek, Selam, Meltem, Tanrıverdi, Özgür, Paydaş, Semra, Urakçı, Zuhat, Atağ, Elif, Güncan, Sabri, Ürün, Yüksel, Alkan, Ali, Kaya, Ali Osman, Özyükseler, Deniz Tataroğlu, Taşkaynatan, Halil, Yıldırım, Mustafa, Sönmez, Müge, Başoğlu, Tuğba, Gündüz, Şeyda, and Kılıçkap, Saadettin

Published
2021
Full Text
View/download PDF

3. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Author

Cascallar, Diana Vera, Varela, Mirta, Lazzaro, Mauricio Fernandez, Kaen, Diego Lucas, Gatica, Gabriela, Flores, David Hugo, Falco, Agustin, Molina, Matias, Van Aelst, Filip, Vulsteke, Christof, Sautois, Brieuc, Machiels, Jean-Pascal, Schallier, Denis, Brust, Leandro, Rapatoni, Liane, Azevedo, Sergio J, Marinho, Gisele, Soares, Joao Paulo Holanda, Dzik, Carlos, Almeida Silva, Jamile, Fay, Andre Poisl, Gingerich, Joel, Fradet, Yves, Ferrario, Cristiano, Potvin, Kylea, Vanhuyse, Marie, Abdelsalam, Mahmoud, Cheng, Susanna, Caglevic, Christian, Reyes, Felipe, Leal, Jose Luis, Francisco, Francisco, Ibanez, Carolina, Joly, Florence, Laguerre, Brigitte, Ladoire, Sylvain, Flechon, Aude, Topart, Delphine, Huillard, Olivier, Oudard, Stéphane, Gross-Goupil, Marine, Culine, Stephane, Loriot, Yohann, Gravis, Gwenaelle, Reichardt, Peter, Retz, Margitta, Herden, Jan, Pfister, David, Ohlman, Carsten, Stoeckle, Michael, Wirth, Manfred, Lorch, Anja, Niegisch, Guenter, Goebell, Peter J, Boegemann, Martin, Merseburger, Axel, Gakis, Georgios, Bedke, Jens, Neisius, Andreas, Thomas, Christian, Hoefner, Thomas, Telekes, Andras, Kosa, Judit Erzsebet, Revesz, Janos, Bodoky, Gyorgy, Csoszi, Tibor, Csejtei, Andras, Geczi, Lajos, Ruzsa, Agnes, Kolonics, Zsuzsanna, Erfan, Jozsef, McDermott, Ray, Bambury, Richard, Sella, Avishay, Frank, Stephen Jay, Kejzman, Daniel, Goldman, Olesya, Rosenbaum, Eli, Peer, Avivit, Berger, Raanan, Rouvinov, Keren, Sarid, David, Fukasawa, Satoshi, Arai, Gaku, Yamaguchi, Akito, Yokomizo, Akira, Takayama, Tatsuya, Kinoshita, Hidefumi, Kikuchi, Eiji, Mizuno, Ryuichi, Fujii, Yasuhisa, Sassa, Naoto, Matsukawa, Yoshihisa, Fujimoto, Kiyohide, Matsubara, Nobuaki, Tanikawa, Toshiki, Tomita, Yoshihiko, Nishimura, Kazuo, Tsujihata, Masao, Oyama, Masafumi, Masumori, Naoya, Kanayama, Hiroomi, Takano, Toshimi, Miura, Yuji, Miyazaki, Jun, Joraku, Akira, Kimura, Tomokazu, Yamamoto, Yoshiaki, Kobayashi, Kazuki, De Wit, Ronald, Aarts, Maureen, Gerritsen, Winald, Los, Maartje, Beerepoot, Laurens, Izmailov, Adel, Gorelov, Sergey Igorevich, Alekseev, Boris Yakovlevich, Semenov, Andrey, Kostorov, Vladimir Anatolyevich, Alekseev, Sergey M, Zyryanov, Alexander, Oschepkov, Vasiliy Nikolaevich, Shidin, Vladimir Aleksandrovich, Vladimirov, Vladimir Ivanovich, Gafanov, Rustem Airatovich, Karlov, Petr Alexandrovich, Anderson, David Brian, Shepherd, Lucinda, Cohen, Graham Lawrence, Rapoport, Bernardo Louis, Ruff, Paul, Lee, Nari, Bae, Woo Kyun, Lee, Hyo Jin, Herranz, Urbano Anido, Rodriguez-Vida, Alejo, Morales Barrera, Rafael, Grande, Enrique, Alonso Gordoa, Teresa, Guma Padro, Josep, Gauna, Daniel Castellano, Arranz, Jose Angel, Munoz Langa, Jose, Sarrio, Regina Girones, Montesa Pino, Alvaro, Juan Fita, Maria Jose, Su, Yu-Li, Lin, Yung-Chang, Su, Wen-Pin, Shen, Ying-Chun, Chang, Yen-Hwa, Huang, Yi-Hsiu, Sriuranpong, Virote, Chansriwong, Phichai, Srimuninnimit, Vichien, Danchaivijitr, Pongwut, Abali, Huseyin, Yavuz, Sinan, Ozyilkan, Ozgur, Sendur, Mehmet Ali Nahit, Ekenel, Meltem, Ozguroglu, Mustafa, Arslan, Cagatay, Gunduz, Seyda, Ozdogan, Mustafa, Birtle, Alison, Powles, Thomas, Huddart, Robert, de Santis, Maria, Zarkar, Anjali, Evans, Linda, Hussain, Syed, DiSimone, Christopher, Muina, Antonio F, Schlegel, Peter, Jhangiani, Haresh S, Harrison, Michael, Slater, Dennis E, Wright, David, Percent, Ivor J, Lin, Jianqing, Hwang, Clara, Mamtani, Ronac, Gupta, Sumati, Bajaj, Madhuri, Galamaga, Robert, Eklund, John, Wallace, James, Shtivelband, Mikhail, Suh, Jason Jung-Gon, Burhani, Nafisa, Eadens, Matthew, Gunturu, Krishna, Burgess, Earle, Wong, John, Chaudhry, Arvind, Van Veldhuizen, Peter, Graff, Stephanie, Thomas, Christian A, Schnadig, Ian D, Carneiro, Benedito, Hussain, Maha, Morgans, Alicia, Fitzharris, John T, Oliff, Ira A, Vuky, Jacqueline, Hauke, Ralph, Baron, Ari, Joshi, Monika, Bolemon, Britt H, Jiang, Peter, Mega, Anthony E, Markus, Maurice, Pfanzelter, Nicklas, Lawler, William Eyre, Cobb, Patrick Wayne, Courtright, Jay G, Jain, Sharad, Doshi, Gurjyot, Gunuganti, Vijay K, Sartor, Oliver Alton, Cole, Scott W, Babiker, Hani, Uchio, Edward M, Drakaki, Alexandra, Mannuel, Heather D, Alva, Ajjai, Guancial, Elizabeth, Fung, Chunkit, Charles, Anthony, Amato, Robert J, Arriaga, Yull, Bowman, Isaac, Ades, Steven, Dreicer, Robert, Yu, Evan, Quinn, David I, Fleming, Mark, Csőszi, Tibor, Özgüroğlu, Mustafa, Géczi, Lajos, Cheng, Susanna Y-S, Oudard, Stephane, Fléchon, Aude, Yu, Evan Y, Nam, Kijoeng, Imai, Kentaro, and Homet Moreno, Blanca

Published
2021
Full Text
View/download PDF

4. Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

Author

Tural, Deniz, Ölmez, Ömer Fatih, Sümbül, Ahmet Taner, Özhan, Nail, Çakar, Burcu, Köstek, Osman, Ekenel, Meltem, Erman, Mustafa, Coşkun, Hasan Şenol, Selçukbiricik, Fatih, Keskin, Özge, Türköz, Fatma Paksoy, Oruç, Kerem, Bayram, Selami, Bilgetekin, İrem, Yıldız, Birol, Şendur, Mehmet Ali Nahit, Paksoy, Nail, Dirican, Ahmet, Erdem, Dilek, Selam, Meltem, Tanrıverdi, Özgür, Paydaş, Semra, Urakçı, Zuhat, Atağ, Elif, Güncan, Sabri, Ürün, Yüksel, Alkan, Ali, Kaya, Ali Osman, Özyükseler, Deniz Tataroğlu, Taşkaynatan, Halil, Yıldırım, Mustafa, Sönmez, Müge, Başoğlu, Tuğba, Gündüz, Şeyda, Kılıçkap, Saadettin, and Artaç, Mehmet

Published
2021
Full Text
View/download PDF

6. Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Author

Machiels, Jean-Pascal, primary, Tao, Yungan, additional, Licitra, Lisa, additional, Burtness, Barbara, additional, Tahara, Makoto, additional, Rischin, Danny, additional, Alves, Gustavo, additional, Lima, Iane Pinto Figueiredo, additional, Hughes, Brett G M, additional, Pointreau, Yoann, additional, Aksoy, Sercan, additional, Laban, Simon, additional, Greil, Richard, additional, Burian, Martin, additional, Hetnał, Marcin, additional, Delord, Jean-Pierre, additional, Mesía, Ricard, additional, Taberna, Miren, additional, Waldron, John N, additional, Simon, Christian, additional, Grégoire, Vincent, additional, Harrington, Kevin J, additional, Swaby, Ramona F, additional, Zhang, Yayan, additional, Gumuscu, Burak, additional, Bidadi, Behzad, additional, Siu, Lillian L, additional, Hughes, Brett GM, additional, Gao, Bo, additional, McGrath, Margaret, additional, Thurnher, Dietmar, additional, Fuereder, Thorsten, additional, Rottey, Sylvie, additional, Machiels, Jean-Pascal, additional, Clement, Paul M, additional, Henry, Stéphanie, additional, Deheneffe, Stéphanie, additional, Vasconcelos Alves, Gustavo, additional, Mourão Dias, Josiane, additional, De Marchi, Pedro Rafael Martins, additional, Mak, Milena Perez, additional, Pereira de Santana Gomes, Andrea Juliana, additional, Oliveira de Castro Junior, Dalvaro, additional, Motta, Tatiane Cardoso, additional, Agostinho Padoan, Monica Luciana, additional, Victorina, Ana Paula, additional, de Azevedo, Sergio Jobim, additional, Brule, Stephanie, additional, Hilton, John, additional, Wang, Chang Shu, additional, Bouganim, Nathaniel, additional, Webster, Marc, additional, Walker, John, additional, Chua, Neil, additional, Zambrano, Angela Regina, additional, Quiroga Echeverri, Alicia, additional, Niño Gomez, Oscar Mauricio, additional, Ortiz, Carlos Alberto, additional, Rojas, Luis, additional, Cardona Zorilla, Andrés, additional, Urrego Meléndez, Olga Marcela, additional, Holečková, Petra Beran, additional, Melichar, Bohuslav, additional, Cvek, Jakub, additional, Prausová, Jana, additional, Vošmik, Milan, additional, Zasadny, Xavier, additional, Geoffrois, Lionnel, additional, Fietkau, Rainer, additional, Haderlein, Marlen, additional, Mueller, Andreas H, additional, Schroeder, Ursula, additional, Wollenberg, Barbara, additional, Ivanyi, Philipp, additional, Gruenwald, Viktor, additional, Schafhausen, Philippe, additional, Gutfeld, Orit, additional, Gluck, Iris, additional, Popovtzer, Aron, additional, Meirovitz, Amichay, additional, Billan, Salem, additional, Brenner, Baruch, additional, Limon, Dror, additional, Perri, Francesco, additional, Caponigro, Francesco, additional, Violati, Martina, additional, Ferrari, Daris, additional, Nole, Franco, additional, Bertolini, Federica, additional, Livi, Lorenzo, additional, Ghi, Maria Grazia, additional, Imarisio, Ilaria, additional, Homma, Akihiro, additional, Ueda, Tsutomu, additional, Asada, Yukinori, additional, Yamazaki, Tomoko, additional, Matsumoto, Koji, additional, Fujii, Takashi, additional, Ikeda, Sadakatsu, additional, Takahashi, Shunji, additional, Kinoshita, Takashi, additional, Sasaki, Keita, additional, Tsuji, Akihito, additional, Ahn, Myung-Ju, additional, Cho, Byoung Chul, additional, Lee, Keun-Wook, additional, Lee, Ki Hyeong, additional, Choi, Moon Ki, additional, Yun, Hwan Jung, additional, Hendriks, Mathijs P, additional, Oosting, Sjoukje F, additional, Buter, Jan, additional, Van Meerten, Esther, additional, Graham, Jonathan, additional, Kawecki, Andrzej, additional, Debicka, Izabella, additional, Maciejczyk, Adam, additional, Pysz, Maciej, additional, Filarska, Dorota, additional, Koralewski, Piotr, additional, Wygoda, Andrzej, additional, Składowski, Krzysztof, additional, Talerczyk, Małgorzata, additional, Berrocal Jaime, Alfonso, additional, Pérez Segura, Pedro, additional, Braña García, Irene, additional, Basté Rotllan, Neus, additional, Mesía Nin, Ricard, additional, Taberna Sanz, Miren, additional, Iglesias Docampo, Lara, additional, Soria Rivas, Ainara, additional, Rueda Domínguez, Antonio, additional, Trigo Pérez, José Manuel, additional, Hong, Ruey-Long, additional, Li, Shau-Hsuan, additional, Wang, Hung-Ming, additional, Yen, Chia-Jui, additional, Yang, Muh-Hwa, additional, Chang, Yi-Fang, additional, Liu, Yi-Chun, additional, Lin, Jin-Ching, additional, Ekenel, Meltem, additional, Harputluoğlu, Hakan, additional, Özyilkan, Özgür, additional, Bılıcı, Ahmet, additional, Şendur, Mehmet Alı Nahıt, additional, Arslan, Cagatay, additional, Harrington, Kevin, additional, Ramkumar, Shanmugasundaram, additional, Gujral, Dorothy, additional, Stewart, Simon, additional, Powell, Melanie, additional, Sibtain, Amen, additional, Roques, Tom, additional, Yip, Kent, additional, Mirza, Arafat, additional, Sivaramalingam, Muthiah, additional, Belman, Neil D, additional, Agarwala, Sanjiv, additional, Anderson, Ian, additional, Patel, Arpan, additional, Maggiore, Ronald, additional, Baumgart, Megan, additional, Fidler, Mary Jo, additional, Kaur, Varinder, additional, Gaughan, Elizabeth, additional, Worden, Francis, additional, Rodriguez, Cristina P, additional, Sukari, Ammar, additional, Wong, Deborah, additional, Yom, Sue, additional, Walsh, William V, additional, Fiorillo, Joseph A, additional, Yorio, Jeffrey T, additional, and Obara, Grzegorz S, additional

Published
2024
Full Text
View/download PDF

7. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Author

Lerzo, Guillermo, Tatangelo, Marcelo, Varela, Mirta, Zarba, Juan Jose, Boyer, Michael, Gan, Hui, Gao, Bo, Hughes, Brett, Mallesara, Girish, Rischin, Danny, Taylor, Anne, Burian, Martin, Fuereder, Thorsten, Greil, Richard, Barrios, Carlos Henrique, de Castro Junior, Dalvaro Oliveira, Castro, Gilberto, Franke, Fabio Andre, Girotto, Gustavo, Lima, Iane Pinto Figueiredo, Nicolau, Ulisses Ribaldo, Pinto, Gustavo Dix Junqueira, Santos, Lucas, Victorino, Ana-Paula, Chua, Neil, Couture, Felix, Gregg, Richard, Hansen, Aaron, Hilton, John, McCarthy, Joy, Soulieres, Denis, Ascui, Rodrigo, Gonzalez, Pablo, Villanueva, Luis, Torregroza, Marco, Zambrano, Angela, Holeckova, Petra, Kral, Zdenek, Melichar, Bohuslav, Prausova, Jana, Vosmik, Milan, Andersen, Maria, Gyldenkerne, Niels, Jurgens, Hannes, Putnik, Kadri, Reinikainen, Petri, Gruenwald, Viktor, Laban, Simon, Aravantinos, Gerasimos, Boukovinas, Ioannis, Georgoulias, Vassilis, Psyrri, Amanda, Kwong, Dora, Al-Farhat, Yousuf, Csoszi, Tibor, Erfan, Jozsef, Horvai, Geza, Landherr, Laszlo, Remenar, Eva, Ruzsa, Agnes, Szota, Judit, Billan, Salem, Gluck, Iris, Gutfeld, Orit, Popovtzer, Aron, Benasso, Marco, Bui, Simona, Ferrari, Vittorio, Licitra, Lisa, Nole, Franco, Fujii, Takashi, Fujimoto, Yasushi, Hanai, Nobuhiro, Hara, Hiroki, Matsumoto, Koji, Mitsugi, Kenji, Monden, Nobuya, Nakayama, Masahiro, Okami, Kenji, Oridate, Nobuhiko, Shiga, Kiyoto, Shimizu, Yasushi, Sugasawa, Masashi, Tahara, Makoto, Takahashi, Masanobu, Takahashi, Shunji, Tanaka, Kaoru, Ueda, Tsutomu, Yamaguchi, Hironori, Yamazaki, Tomoko, Yasumatsu, Ryuji, Yokota, Tomoya, Yoshizaki, Tomokazu, Kudaba, Iveta, Stara, Zinaida, Wan Ishak, Wan Zamaniah, Cheah, Soon Keat, Aguilar Ponce, Jose, Gonzalez Mendoza, Rene, Hernandez Hernandez, Carlos, Medina Soto, Francisco, Buter, Jan, Hoeben, Ann, Oosting, S., Suijkerbuijk, Karijn, Bratland, Aase, Brydoey, Marianne, Alvarez, Renzo, Mas, Luis, Caguioa, Priscilla, Querol, John, Regala, Eugenio Emmanuel, Tamayo, Maria Belen, Villegas, Ellie May, Kawecki, Andrzej, Karpenko, Andrey, Klochikhin, Arkadiy, Smolin, Alexey, Zarubenkov, Oleg, Goh, Boon Cher, Cohen, Graham, du Toit, Johanna, Jordaan, Christa, Landers, Gregory, Ruff, Paul, Szpak, Waldemar, Tabane, Neonyana, Brana, Irene, Iglesias Docampo, Lara, Lavernia, Javier, Mesia, Ricard, Abel, Edvard, Muratidu, Valentina, Nielsen, Niels, Cristina, Valerie, Rordorf, Tamara, Rothschild, Sacha, Hong, Ruey-Long, Wang, Hung-Ming, Yang, Muh-Hwa, Yeh, Su-Peng, Yen, Chia-Jui, Ngamphaiboon, Nuttapong, Soparattanapaisarn, Nopadol, Sriuranpong, Virote, Aksoy, Sercan, Cicin, Irfan, Ekenel, Meltem, Harputluoglu, Hakan, Ozyilkan, Ozgur, Harrington, Kevin, Agarwala, Sanjiv, Ali, Haythem, Alter, Robert, Anderson, Daniel, Bruce, Justine, Burtness, Barbara, Campbell, Nicholas, Conde, Miguel, Deeken, John, Edenfield, William, Feldman, Lawrence, Gaughan, Elizabeth, Goueli, Basem, Halmos, Balazs, Hegde, Upendra, Hunis, Brian, Jotte, Robert, Karnad, Anand, Khan, Saad, Laudi, Noel, Laux, Douglas, Martincic, Danko, McCune, Steven, McGaughey, Dean, Misiukiewicz, Krzysztof, Mulford, Deborah, Nadler, Eric, Neupane, Prakash, Nunnink, Johannes, Ohr, James, O'Malley, Meaghan, Patson, Brian, Paul, Doru, Popa, Elizabeta, Powell, Steven, Redman, Rebecca, Rella, Vincent, Rocha Lima, Chaio, Sivapiragasam, Abirami, Su, Yungpo, Sukari, Ammar, Wong, Stuart, Yilmaz, Emrullah, Yorio, Jeffrey, Harrington, Kevin J, Soulières, Denis, de Castro, Gilberto, Jr, Basté, Neus, Bratland, Åse, Hughes, Brett G M, Mesía, Ricard, González Mendoza, René, Roy, Ananya, Zhang, Yayan, Gumuscu, Burak, Cheng, Jonathan D, and Jin, Fan

Published
2019
Full Text
View/download PDF

13. Pazopanib Treatment in Soft Tissue Sarcoma (Single Center Experience).

Author

Pehlivan, Metin, Basaran, Mert, and Ekenel, Meltem

Subjects
VASCULAR endothelial growth factor antagonists, DRUG efficacy, CANCER chemotherapy, ANTINEOPLASTIC agents, RETROSPECTIVE studies, SOFT tissue tumors, PROTEIN-tyrosine kinase inhibitors, DESCRIPTIVE statistics, PROGRESSION-free survival, DATA analysis software, SARCOMA, OVERALL survival, PATIENT safety, PALLIATIVE treatment, PHARMACODYNAMICS
Abstract

Objectives: Soft tissue sarcomas are a heterogeneous group of tumors accounting for less than 1% of adult malignancies. In this study, we examined patients who received pazopanib for soft tissue sarcoma. Factors affecting mortality and overall survival in soft tissue sarcoma patients using pazopanib were investigated. Methods: This study is a retrospective single-center study. Results: Fifty-three patients (median age: 42 years) were included. The median duration of follow-up in our cohort was 34 months. Before pazopanib, 37 patients (69.8%) received first-line, 12 patients (22.6%) received second-line and 4 patients (7.5%) received third-line chemotherapy. The median duration of pazopanib therapy was 7 months (range, 1-82). Median progression-free survival (PFS) and median overall survival was 7 months (range, 1-83) and 12 months (range, 1-83), respectively. Patients who received radiotherapy for curative or palliative purposes had significantly longer PFS (p=0.040). Eight patients required dose reduction due to adverse effects. Grade 4 adverse effects occurred in only 2 patients. After pazopanib, 36 patients (67.9%) did not receive any treatment. On Cox regression analysis, not receiving any treatment after pazopanib was associated with 3.052-fold higher mortality. A 1-unit increase in PFS was associated with 1.15-fold lower risk of mortality. Conclusion: In this study, pazopanib was found to be an effective and safe drug for advanced soft tissue sarcoma. Patients who received palliative radiotherapy for curative or palliative purposes had significantly longer PFS. Receiving treatment after pazopanib and longer PFS was associated with reduced mortality. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

15. Research Data for Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience

Author

Pehlivan, Metin, İribaş, Ayça, Bilgiç, Bilge, Başaran, Mert, and Ekenel, Meltem

Subjects
111199 Nutrition and Dietetics not elsewhere classified, Cardiology, 170199 Psychology not elsewhere classified, 111799 Public Health and Health Services not elsewhere classified, 110604 Sports Medicine, FOS: Health sciences, 110306 Endocrinology, 110308 Geriatrics and Gerontology, 111099 Nursing not elsewhere classified, 111708 Health and Community Services, 160807 Sociological Methodology and Research Methods, 111702 Aged Health Care, 111403 Paediatrics, 110904 Neurology and Neuromuscular Diseases, 110203 Respiratory Diseases, 110315 Otorhinolaryngology, FOS: Clinical medicine, 110319 Psychiatry (incl. Psychotherapy), FOS: Sociology, FOS: Psychology, 110599 Dentistry not elsewhere classified, 110323 Surgery, 110305 Emergency Medicine, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified, 110314 Orthopaedics
Abstract

Research Data for Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience by Metin Pehlivan, Ayça İribaş, Bilge Bilgiç, Mert Başaran and Meltem Ekenel in Journal of International Medical Research

Published
2023
Full Text
View/download PDF

21. Clinical Course and Features of Head and Neck Soft Tissue Sarcomas (Single Center Experience)

Author

PEHLİVAN, Metin, İRİBAŞ, Ayça, BİLGİÇ, Bilge, BAŞARAN, Mert, and EKENEL, Meltem

Subjects
Health Care Sciences and Services, Soft Tissue Sarcomas, Head and neck Cancer, Oncology, Yumuşak Doku Sarkomları, Baş Boyun Kanserleri, Onkoloji, Sağlık Bilimleri ve Hizmetleri
Abstract

Amaç: Yumuşak doku sarkomları genellikle ekstremitelerde veya retroperitonda görülür, %5-10 hastadaise baş boyun bölgesinde görülür. Yumuşak doku sarkomları baş ve boyun kanserlerinin, Aim: Soft tissue sarcomas are usually seen in the extremities or the retroperitoneum, and are seen inthe head and neck region in 5-10% of patients. Soft tissue sarcomas account for

Published
2022

25. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Author

Powles, Thomas, primary, Csőszi, Tibor, additional, Özgüroğlu, Mustafa, additional, Matsubara, Nobuaki, additional, Géczi, Lajos, additional, Cheng, Susanna Y-S, additional, Fradet, Yves, additional, Oudard, Stephane, additional, Vulsteke, Christof, additional, Morales Barrera, Rafael, additional, Fléchon, Aude, additional, Gunduz, Seyda, additional, Loriot, Yohann, additional, Rodriguez-Vida, Alejo, additional, Mamtani, Ronac, additional, Yu, Evan Y, additional, Nam, Kijoeng, additional, Imai, Kentaro, additional, Homet Moreno, Blanca, additional, Alva, Ajjai, additional, Cascallar, Diana Vera, additional, Varela, Mirta, additional, Lazzaro, Mauricio Fernandez, additional, Kaen, Diego Lucas, additional, Gatica, Gabriela, additional, Flores, David Hugo, additional, Falco, Agustin, additional, Molina, Matias, additional, Van Aelst, Filip, additional, Sautois, Brieuc, additional, Machiels, Jean-Pascal, additional, Schallier, Denis, additional, Brust, Leandro, additional, Rapatoni, Liane, additional, Azevedo, Sergio J, additional, Marinho, Gisele, additional, Soares, Joao Paulo Holanda, additional, Dzik, Carlos, additional, Almeida Silva, Jamile, additional, Fay, Andre Poisl, additional, Gingerich, Joel, additional, Ferrario, Cristiano, additional, Potvin, Kylea, additional, Vanhuyse, Marie, additional, Abdelsalam, Mahmoud, additional, Cheng, Susanna, additional, Caglevic, Christian, additional, Reyes, Felipe, additional, Leal, Jose Luis, additional, Francisco, Francisco, additional, Ibanez, Carolina, additional, Joly, Florence, additional, Laguerre, Brigitte, additional, Ladoire, Sylvain, additional, Flechon, Aude, additional, Topart, Delphine, additional, Huillard, Olivier, additional, Oudard, Stéphane, additional, Gross-Goupil, Marine, additional, Culine, Stephane, additional, Gravis, Gwenaelle, additional, Reichardt, Peter, additional, Retz, Margitta, additional, Herden, Jan, additional, Pfister, David, additional, Ohlman, Carsten, additional, Stoeckle, Michael, additional, Wirth, Manfred, additional, Lorch, Anja, additional, Niegisch, Guenter, additional, Goebell, Peter J, additional, Boegemann, Martin, additional, Merseburger, Axel, additional, Gakis, Georgios, additional, Bedke, Jens, additional, Neisius, Andreas, additional, Thomas, Christian, additional, Hoefner, Thomas, additional, Telekes, Andras, additional, Kosa, Judit Erzsebet, additional, Revesz, Janos, additional, Bodoky, Gyorgy, additional, Csoszi, Tibor, additional, Csejtei, Andras, additional, Geczi, Lajos, additional, Ruzsa, Agnes, additional, Kolonics, Zsuzsanna, additional, Erfan, Jozsef, additional, McDermott, Ray, additional, Bambury, Richard, additional, Sella, Avishay, additional, Frank, Stephen Jay, additional, Kejzman, Daniel, additional, Goldman, Olesya, additional, Rosenbaum, Eli, additional, Peer, Avivit, additional, Berger, Raanan, additional, Rouvinov, Keren, additional, Sarid, David, additional, Fukasawa, Satoshi, additional, Arai, Gaku, additional, Yamaguchi, Akito, additional, Yokomizo, Akira, additional, Takayama, Tatsuya, additional, Kinoshita, Hidefumi, additional, Kikuchi, Eiji, additional, Mizuno, Ryuichi, additional, Fujii, Yasuhisa, additional, Sassa, Naoto, additional, Matsukawa, Yoshihisa, additional, Fujimoto, Kiyohide, additional, Tanikawa, Toshiki, additional, Tomita, Yoshihiko, additional, Nishimura, Kazuo, additional, Tsujihata, Masao, additional, Oyama, Masafumi, additional, Masumori, Naoya, additional, Kanayama, Hiroomi, additional, Takano, Toshimi, additional, Miura, Yuji, additional, Miyazaki, Jun, additional, Joraku, Akira, additional, Kimura, Tomokazu, additional, Yamamoto, Yoshiaki, additional, Kobayashi, Kazuki, additional, De Wit, Ronald, additional, Aarts, Maureen, additional, Gerritsen, Winald, additional, Los, Maartje, additional, Beerepoot, Laurens, additional, Izmailov, Adel, additional, Gorelov, Sergey Igorevich, additional, Alekseev, Boris Yakovlevich, additional, Semenov, Andrey, additional, Kostorov, Vladimir Anatolyevich, additional, Alekseev, Sergey M, additional, Zyryanov, Alexander, additional, Oschepkov, Vasiliy Nikolaevich, additional, Shidin, Vladimir Aleksandrovich, additional, Vladimirov, Vladimir Ivanovich, additional, Gafanov, Rustem Airatovich, additional, Karlov, Petr Alexandrovich, additional, Anderson, David Brian, additional, Shepherd, Lucinda, additional, Cohen, Graham Lawrence, additional, Rapoport, Bernardo Louis, additional, Ruff, Paul, additional, Lee, Nari, additional, Bae, Woo Kyun, additional, Lee, Hyo Jin, additional, Herranz, Urbano Anido, additional, Grande, Enrique, additional, Alonso Gordoa, Teresa, additional, Guma Padro, Josep, additional, Gauna, Daniel Castellano, additional, Arranz, Jose Angel, additional, Munoz Langa, Jose, additional, Sarrio, Regina Girones, additional, Montesa Pino, Alvaro, additional, Juan Fita, Maria Jose, additional, Su, Yu-Li, additional, Lin, Yung-Chang, additional, Su, Wen-Pin, additional, Shen, Ying-Chun, additional, Chang, Yen-Hwa, additional, Huang, Yi-Hsiu, additional, Sriuranpong, Virote, additional, Chansriwong, Phichai, additional, Srimuninnimit, Vichien, additional, Danchaivijitr, Pongwut, additional, Abali, Huseyin, additional, Yavuz, Sinan, additional, Ozyilkan, Ozgur, additional, Sendur, Mehmet Ali Nahit, additional, Ekenel, Meltem, additional, Ozguroglu, Mustafa, additional, Arslan, Cagatay, additional, Ozdogan, Mustafa, additional, Birtle, Alison, additional, Powles, Thomas, additional, Huddart, Robert, additional, de Santis, Maria, additional, Zarkar, Anjali, additional, Evans, Linda, additional, Hussain, Syed, additional, DiSimone, Christopher, additional, Muina, Antonio F, additional, Schlegel, Peter, additional, Jhangiani, Haresh S, additional, Harrison, Michael, additional, Slater, Dennis E, additional, Wright, David, additional, Percent, Ivor J, additional, Lin, Jianqing, additional, Hwang, Clara, additional, Gupta, Sumati, additional, Bajaj, Madhuri, additional, Galamaga, Robert, additional, Eklund, John, additional, Wallace, James, additional, Shtivelband, Mikhail, additional, Suh, Jason Jung-Gon, additional, Burhani, Nafisa, additional, Eadens, Matthew, additional, Gunturu, Krishna, additional, Burgess, Earle, additional, Wong, John, additional, Chaudhry, Arvind, additional, Van Veldhuizen, Peter, additional, Graff, Stephanie, additional, Thomas, Christian A, additional, Schnadig, Ian D, additional, Carneiro, Benedito, additional, Hussain, Maha, additional, Morgans, Alicia, additional, Fitzharris, John T, additional, Oliff, Ira A, additional, Vuky, Jacqueline, additional, Hauke, Ralph, additional, Baron, Ari, additional, Joshi, Monika, additional, Bolemon, Britt H, additional, Jiang, Peter, additional, Mega, Anthony E, additional, Markus, Maurice, additional, Pfanzelter, Nicklas, additional, Lawler, William Eyre, additional, Cobb, Patrick Wayne, additional, Courtright, Jay G, additional, Jain, Sharad, additional, Doshi, Gurjyot, additional, Gunuganti, Vijay K, additional, Sartor, Oliver Alton, additional, Cole, Scott W, additional, Babiker, Hani, additional, Uchio, Edward M, additional, Drakaki, Alexandra, additional, Mannuel, Heather D, additional, Guancial, Elizabeth, additional, Fung, Chunkit, additional, Charles, Anthony, additional, Amato, Robert J, additional, Arriaga, Yull, additional, Bowman, Isaac, additional, Ades, Steven, additional, Dreicer, Robert, additional, Yu, Evan, additional, Quinn, David I, additional, and Fleming, Mark, additional

Published
2021
Full Text
View/download PDF

26. 9. Challenges in caring for oncology patients during the COVID-19 pandemic in Istanbul, Turkey

Author

Bingol, Hulya, Karap��nar, Ayla, Ekenel, Meltem, and Kebudi, Rejin

Abstract

TURKEYBingol, paediatric oncology nurses, and a paediatric oncologist report on the situation at the Istanbul University Hospital. They mention, ���Although the number of patients with COVID-19 had decreased significantly through the [early] strict regulations, after the summer vacation and holidays the numbers increased in Turkey, in Istanbul, and on our campus, increasing the anxiety in our patients, caregivers, and healthcare staff. Psychological support for the nurses and other healthcare professionals are important.���---- Ecancer Special Issue, December 2021 Oncology nursing and the psychosocial impact of COVID-19 in the Global South Supplement

Published
2021
Full Text
View/download PDF

33. Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors.

Author

Paksoy, Nail, Ferhatoglu, Ferhat, Dogan, Izzet, Ak, Naziye, Pehlivan, Metin, Ekenel, Meltem, and Basaran, Mert

Subjects
DRUG efficacy, GARDNER syndrome, SORAFENIB, PROGRESSION-free survival, CONNECTIVE tissue tumors, EVALUATION
Abstract

Objectives: Desmoid tumors (DTs) are rare benign neoplasms characterized by histologically monoclonal fibroblastic proliferation. Although current treatment guidelines recommend active surveillance as the initial approach, systemic therapy should be considered in rapidly progressive or symptomatic patients. In this study, we aimed to evaluate the efficacy of the kinase inhibitor, sorafenib, as a treatment for patients with progressive or symptomatic DTs. Methods: The clinical, pathological, and demographic data of a sample of patients treated for DTs with sorafenib were retrospectively evaluated. Results: Seventeen patients were included in the study. The ratio of female to male patients was 2.4, and the median age was 32 (range: 14-65). Four (23.5%) patients had Gardner syndrome. The rates of extra-abdominal and ıntraintraabdominal tumors were 64.7% and 35.3%, respectively. The median follow-up duration before sorafenib treatment began was 6 years. Before sorafenib, 15 patients had undergone surgical resection. All patients had received a median of two lines of systemic therapy, and four (23.5%) patients had received chemotherapy. The median sorafenib treatment duration was 23.4 months. The 1 and 2 year progression-free survival rates were 94.1% and 80.7%, respectively. Grade 3–4 toxicities were observed in six (35.2%) of the patients. Conclusion: Sorafenib was deemed an effective treatment for previously treated advanced DTs. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

38. Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma.

Author

Tural, Deniz, primary, Olmez, Omer Fatih, additional, Sümbül, Ahmet Taner, additional, Artac, Mehmet, additional, Ozhan, Nail, additional, Akar, Emre, additional, Cakar, Burcu, additional, Kostek, Osman, additional, Ekenel, Meltem, additional, Coskun, Hasan Senol, additional, Selcukbiricik, Fatih, additional, Keskin, Özge, additional, Paksoy Turkoz, Fatma, additional, oruc, kerem, additional, Bayram, Selami, additional, Yilmaz, Ugur, additional, Bilgetekin, Irem, additional, Yildiz, Birol, additional, Sendur, Mehmet Ali Nahit, additional, and Erman, Mustafa, additional

Published
2021
Full Text
View/download PDF

44. Third-line Therapy for Metastatic Renal Cell Carcinoma and Its Effect on Quality of Life and Overall Survival: A National, Multicenter, Observational Study

Author

ÇİÇİN, İrfan, primary, ÇİLTAŞ, Aydın, additional, KILIÇKAP, Saadettin, additional, ÖKSÜZOĞLU, Berna, additional, UNCU, Doğan, additional, ARTAÇ, Mehmet, additional, YEŞİL ÇINKIR, Havva, additional, IŞIKDOĞAN, Abdurrahman, additional, DANE, Faysal, additional, ALİUSTAOĞLU, Mehmet, additional, TÜRK, Hacı Mehmet, additional, ELKIRAN, Emin Tamer, additional, ÇUBUKÇU, Erdem, additional, EKENEL, Meltem, additional, ÖZDEMİR, Feyyaz, additional, GÖKYER, Ali, additional, ÖZTOP, İlhan, additional, ALACACIOĞLU, Ahmet, additional, ÖZTÜRK, Hüseyin, additional, AVER, Birkan, additional, and ÖZKAN, Metin, additional

Published
2020
Full Text
View/download PDF

45. Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.

Author

Paksoy, Nail, Erdem, Selcuk, Karaca, Mert, Ak, Naziye, Pehlivan, Metin, Yirgin, Inci K., Ozluk, Yasemin, Ekiz, Feza, Tural, Deniz, Ekenel, Meltem, Ozcan, Faruk, and Basaran, Mert

Subjects
THERAPEUTIC use of antineoplastic agents, RENAL cell carcinoma, RETROPERITONEUM, DISEASE progression, PUBLIC health surveillance, NAUSEA, IMMUNOHISTOCHEMISTRY, METASTASIS, TREATMENT effectiveness, PROTEIN-tyrosine kinase inhibitors, ABDOMINAL tumors, TRANSCRIPTION factors, TUMOR markers, COMPUTED tomography, ABDOMINAL radiography, IMMUNOTHERAPY
Abstract

Background: Transcription factor E3 (TFE3) related renal cell carcinomas constitute a very small percent of all renal tumors in adults. Prognosis mainly depends on the stage of the disease at the time of diagnosis which is often poor. There is yet to be a standardized treatment protocol. Treatment options include agents identical to TFE3(–) cell renal carcinoma treatment. We present a case of a young woman with a rapidly progressing metastatic TFE3 (+) renal cell carcinoma. Case report: A 31 year old female presented with abdominal mass, distension, nausea. Initial tests and tumor markers found to be normal. Abdominal CT scan revealed a left retroperitoneal mass along with three other neighboring masses in liver manifesting as metastases. Trucut biopsy and immunohistochemical staining confirmed the retroperitoneal mass as TFE3 (+) renal cell carcinoma. Management and outcome: Sunitinib, pazopanib, nivolumab, axitinib treatments are consecutively given after surgery. It is noteworthy that rapid progression was observed under nivolumab treatment. Discussion: During surveillance, rapid progression is noted under consecutive immunotherapy which was unexpected. Thus, there is a need for more standardized treatment protocols and invention of new agents for management of TFE3 (+) renal cell carcinoma. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

50. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Author

Burtness, Barbara, primary, Harrington, Kevin J, additional, Greil, Richard, additional, Soulières, Denis, additional, Tahara, Makoto, additional, de Castro, Gilberto, additional, Psyrri, Amanda, additional, Basté, Neus, additional, Neupane, Prakash, additional, Bratland, Åse, additional, Fuereder, Thorsten, additional, Hughes, Brett G M, additional, Mesía, Ricard, additional, Ngamphaiboon, Nuttapong, additional, Rordorf, Tamara, additional, Wan Ishak, Wan Zamaniah, additional, Hong, Ruey-Long, additional, González Mendoza, René, additional, Roy, Ananya, additional, Zhang, Yayan, additional, Gumuscu, Burak, additional, Cheng, Jonathan D, additional, Jin, Fan, additional, Rischin, Danny, additional, Lerzo, Guillermo, additional, Tatangelo, Marcelo, additional, Varela, Mirta, additional, Zarba, Juan Jose, additional, Boyer, Michael, additional, Gan, Hui, additional, Gao, Bo, additional, Hughes, Brett, additional, Mallesara, Girish, additional, Taylor, Anne, additional, Burian, Martin, additional, Barrios, Carlos Henrique, additional, de Castro Junior, Dalvaro Oliveira, additional, Castro, Gilberto, additional, Franke, Fabio Andre, additional, Girotto, Gustavo, additional, Lima, Iane Pinto Figueiredo, additional, Nicolau, Ulisses Ribaldo, additional, Pinto, Gustavo Dix Junqueira, additional, Santos, Lucas, additional, Victorino, Ana-Paula, additional, Chua, Neil, additional, Couture, Felix, additional, Gregg, Richard, additional, Hansen, Aaron, additional, Hilton, John, additional, McCarthy, Joy, additional, Soulieres, Denis, additional, Ascui, Rodrigo, additional, Gonzalez, Pablo, additional, Villanueva, Luis, additional, Torregroza, Marco, additional, Zambrano, Angela, additional, Holeckova, Petra, additional, Kral, Zdenek, additional, Melichar, Bohuslav, additional, Prausova, Jana, additional, Vosmik, Milan, additional, Andersen, Maria, additional, Gyldenkerne, Niels, additional, Jurgens, Hannes, additional, Putnik, Kadri, additional, Reinikainen, Petri, additional, Gruenwald, Viktor, additional, Laban, Simon, additional, Aravantinos, Gerasimos, additional, Boukovinas, Ioannis, additional, Georgoulias, Vassilis, additional, Kwong, Dora, additional, Al-Farhat, Yousuf, additional, Csoszi, Tibor, additional, Erfan, Jozsef, additional, Horvai, Geza, additional, Landherr, Laszlo, additional, Remenar, Eva, additional, Ruzsa, Agnes, additional, Szota, Judit, additional, Billan, Salem, additional, Gluck, Iris, additional, Gutfeld, Orit, additional, Popovtzer, Aron, additional, Benasso, Marco, additional, Bui, Simona, additional, Ferrari, Vittorio, additional, Licitra, Lisa, additional, Nole, Franco, additional, Fujii, Takashi, additional, Fujimoto, Yasushi, additional, Hanai, Nobuhiro, additional, Hara, Hiroki, additional, Matsumoto, Koji, additional, Mitsugi, Kenji, additional, Monden, Nobuya, additional, Nakayama, Masahiro, additional, Okami, Kenji, additional, Oridate, Nobuhiko, additional, Shiga, Kiyoto, additional, Shimizu, Yasushi, additional, Sugasawa, Masashi, additional, Takahashi, Masanobu, additional, Takahashi, Shunji, additional, Tanaka, Kaoru, additional, Ueda, Tsutomu, additional, Yamaguchi, Hironori, additional, Yamazaki, Tomoko, additional, Yasumatsu, Ryuji, additional, Yokota, Tomoya, additional, Yoshizaki, Tomokazu, additional, Kudaba, Iveta, additional, Stara, Zinaida, additional, Cheah, Soon Keat, additional, Aguilar Ponce, Jose, additional, Gonzalez Mendoza, Rene, additional, Hernandez Hernandez, Carlos, additional, Medina Soto, Francisco, additional, Buter, Jan, additional, Hoeben, Ann, additional, Oosting, S., additional, Suijkerbuijk, Karijn, additional, Bratland, Aase, additional, Brydoey, Marianne, additional, Alvarez, Renzo, additional, Mas, Luis, additional, Caguioa, Priscilla, additional, Querol, John, additional, Regala, Eugenio Emmanuel, additional, Tamayo, Maria Belen, additional, Villegas, Ellie May, additional, Kawecki, Andrzej, additional, Karpenko, Andrey, additional, Klochikhin, Arkadiy, additional, Smolin, Alexey, additional, Zarubenkov, Oleg, additional, Goh, Boon Cher, additional, Cohen, Graham, additional, du Toit, Johanna, additional, Jordaan, Christa, additional, Landers, Gregory, additional, Ruff, Paul, additional, Szpak, Waldemar, additional, Tabane, Neonyana, additional, Brana, Irene, additional, Iglesias Docampo, Lara, additional, Lavernia, Javier, additional, Mesia, Ricard, additional, Abel, Edvard, additional, Muratidu, Valentina, additional, Nielsen, Niels, additional, Cristina, Valerie, additional, Rothschild, Sacha, additional, Wang, Hung-Ming, additional, Yang, Muh-Hwa, additional, Yeh, Su-Peng, additional, Yen, Chia-Jui, additional, Soparattanapaisarn, Nopadol, additional, Sriuranpong, Virote, additional, Aksoy, Sercan, additional, Cicin, Irfan, additional, Ekenel, Meltem, additional, Harputluoglu, Hakan, additional, Ozyilkan, Ozgur, additional, Harrington, Kevin, additional, Agarwala, Sanjiv, additional, Ali, Haythem, additional, Alter, Robert, additional, Anderson, Daniel, additional, Bruce, Justine, additional, Burtness, Barbara, additional, Campbell, Nicholas, additional, Conde, Miguel, additional, Deeken, John, additional, Edenfield, William, additional, Feldman, Lawrence, additional, Gaughan, Elizabeth, additional, Goueli, Basem, additional, Halmos, Balazs, additional, Hegde, Upendra, additional, Hunis, Brian, additional, Jotte, Robert, additional, Karnad, Anand, additional, Khan, Saad, additional, Laudi, Noel, additional, Laux, Douglas, additional, Martincic, Danko, additional, McCune, Steven, additional, McGaughey, Dean, additional, Misiukiewicz, Krzysztof, additional, Mulford, Deborah, additional, Nadler, Eric, additional, Nunnink, Johannes, additional, Ohr, James, additional, O'Malley, Meaghan, additional, Patson, Brian, additional, Paul, Doru, additional, Popa, Elizabeta, additional, Powell, Steven, additional, Redman, Rebecca, additional, Rella, Vincent, additional, Rocha Lima, Chaio, additional, Sivapiragasam, Abirami, additional, Su, Yungpo, additional, Sukari, Ammar, additional, Wong, Stuart, additional, Yilmaz, Emrullah, additional, and Yorio, Jeffrey, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results